Showing results (341-350 of 406) with videos related to

Sort By:
Pageof 41
Acta Neuropathologica|December 26, 2018
The impact of histopathology and NAB2-STAT6 fusion subtype in classification and grading of meningeal solitary fibrous tumor/hemangiopericytomaKaren Fritchie, Kassandra Jensch, Evgeny A Moskalev, et al.
Neurosurgery|August 30, 2020
A Prognostic Gene-Expression Signature and Risk Score for Meningioma Recurrence After ResectionWilliam C Chen, Harish N Vasudevan, Abrar Choudhury, et al.
Archives of Pathology & Laboratory Medicine|February 17, 2022
Molecular Biomarker Testing for the Diagnosis of Diffuse GliomasDaniel J Brat, Kenneth Aldape, Julia A Bridge, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 5, 2024
Canadian Consensus Guidelines for the Diagnosis and Treatment of Autoimmune Encephalitis in AdultsChristopher Hahn, Adrian Budhram, Katayoun Alikhani, et al.
JCI Insight|September 23, 2025
Tumor heterogeneity underlies clinical outcome and MEK inhibitor response in somatic NF1-mutant glioblastomaSixuan Pan, Kanish Mirchia, Emily Payne, et al.
Nature Communications|January 12, 2024
Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistanceHarish N Vasudevan, Emily Payne, Cyrille L Delley, et al.
Neuro-Oncology Advances|May 19, 2021
The state of neuro-oncology during the COVID-19 pandemic: a worldwide assessmentMaciej M Mrugala, Quinn T Ostrom, Shelley M Pressley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2017
Prospective Feasibility Trial for Genomics-Informed Treatment in Recurrent and Progressive GlioblastomaSara A Byron, Nhan L Tran, Rebecca F Halperin, et al.
Cancer Discovery|July 25, 2020
The Meningioma Enhancer Landscape Delineates Novel Subgroups and Drives Druggable DependenciesBriana C Prager, Harish N Vasudevan, Deobrat Dixit, et al.
Neuro-Oncology|June 3, 2022
Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539C Leland Rogers, Stephanie L Pugh, Michael A Vogelbaum, et al.
Pageof 41